BIO-Europe Spring 2012 to Be Held in Amsterdam March 19–21

BIO-Europe Spring 2012 will be held in Amsterdam March 19–21, 2012 at the Amsterdam RAI Convention Center.

BIO-Europe Spring 2012 will be held in Amsterdam March 19–21, 2012 at the Amsterdam RAI Convention Center.

The event will present a dynamic plenary session entitled, “Are orphan indications the only viable model for future drug development?” The panel will be moderated by Vaughn Kailian of MPM Capital, with panelists Roger Longman of Real Endpoints; Anna Protopapas, Takeda Pharmaceuticals; Hans Schikan of Prosensa; and Philip Vickers, Shire Human Genetic Therapies.

BIO-Europe Spring will also feature other meaningful presentations on the importance of life science partnering, including Monday's panel, “The opportunity of community drug development partnerships for personalized oncology and drug development.”